• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHL2100066 AM006 AM-006 Active ingredient Chemical Drugs(1) Import Drug Application 2021-03-02 上海艾迈医疗科技有限公司 7 Items of Kangqiao Capital Questionnaire 2019q4 Affamedtherapeutics Limited In Review 2021-03-01 view
JXHL2100065 AM006 AM-006 Active ingredient Chemical Drugs(1) Import Drug Application 2021-03-02 上海艾迈医疗科技有限公司 7 Items of Kangqiao Capital Questionnaire 2019q4 Affamedtherapeutics Limited In Review 2021-03-01 view
JXSL1900088 注射用曲妥珠单抗 trastuzumab Lyophilized Biological Products Import Drug Application 2019-09-11 上海艾迈医疗科技有限公司 7 Items of Kangqiao Capital Questionnaire 2019q4 Affamedtherapeutics Limited In Review 2019-09-10 view
JXSL2000131 雷珠单抗注射液 Ranibizumab Injection Biological Products(3.3) Import Drug Application 2020-07-17 上海艾迈医疗科技有限公司 7 Items of Kangqiao Capital Questionnaire 2019q4 Affamedtherapeutics Limited In Review 2020-07-16 view